The AES Corp (NYSE: AES) has reported E.P.S. of $0.34 for its third fiscal quarter (ending September 30) versus $0.63 for the same period a year ago — a decline of -46%. Relative to the […]
For its third fiscal quarter (ending September 30), Celldex Therapeutics Inc (NASDAQ: CLDX) has reported E.P.S. of $-0.81 compared to $-0.57 a year ago. This performance was $-0.15 short of the consensus estimate of $-0.66. […]
Intevac Inc (NASDAQ: IVAC) stock closed at $3.48 on 11/2/23 after a major increase of 11.5%. The stock has been extremely weak relative to the market over the last nine months but has risen 9.4% […]
Insulet Corporation (NASDAQ: PODD) has reported E.P.S. of $0.74 for its third fiscal quarter (ending September 30) versus $-0.08 for the same period a year ago. This result exceeded the consensus estimate of $0.41 by […]
On 11/2/23, The9 Ltd (NASDAQ: NCTY) stock enjoyed a major increase of 17.0%, closing at $5.89. Relative to the market the stock has been extremely weak over the last nine months but has risen 9.9% […]
On 11/2/23, 3D Systems Corp (NYSE: DDD) stock enjoyed a major increase of 11.2%, closing at $4.07. Relative to the market the stock has been extremely weak over the last nine months but has risen […]
On 11/2/23, STAAR Surgical Co (NASDAQ: STAA) stock suffered a major decline of -16.9%, closing at $36.01. The stock has declined -7.1% during the last week and has been extremely weak relative to the market […]
Bruker Corporation (NASDAQ: BRKR) has reported E.P.S. of $0.60 for its third fiscal quarter (ending September 30) versus $0.60 for the same period a year ago — flat performance. This result fell short of the […]
For its first fiscal quarter (ending September 30), Viavi Solutions Inc (NASDAQ: VIAV) has reported a -71% decline in E.P.S. from $0.14 a year ago to $0.04 in the current quarter. This performance was $-0.06 […]
Red Robin Gourmet Burgers Inc (NASDAQ: RRGB) stock enjoyed a major increase of 16.3% on 11/2/23. The shares closed at $9.29. The stock has been weak relative to the market over the last nine months […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research